Clinical Trials for TEL-JAK2 Fusion Protein Expression

Find clinical trials for tel-jak2 fusion protein expression. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Ruxolitinib in Treating Patients with Hypereosinophilic Syndrome or Primary Eosinophilic Disorders

NCT ID: NCT03801434

This clinical trial is studying a medication called ruxolitinib to see how well it works for patients with hypereosinophilic syndrome or other related blood disorders. These conditions are characte...

Recruiting

Phase: PHASE2 Type: interventional Locations: Seattle, Washington, United States, Portland, Oregon, United States +2 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions